Funding · Company
NewLimit, Inc.
South San Francisco, CABiotech & Pharma
NewLimit, Inc. of South San Francisco, CA has disclosed $202M across 2 Form D offerings filed with the SEC between Jan 7, 2025 and May 15, 2025.
$202M
Total disclosed
2
Form D offerings
17
Open roles today
Hiring — 17 open roles as of Aug 8, 2026
Based in South San Francisco, South San Francisco, CA. Counted from the company's own public job board.
Offerings on file
Each amount is as reported on that filing, cumulative across its own amendments. Newest first.
$130M
Form D · May 15, 2025 ↗
Q2 2025
· target $130M
$72M
Form D · Jan 7, 2025 ↗
Q1 2025
· 1 amendment, first filed May 17, 2023
Filing details
HeadquartersSouth San Francisco, CAIndustryBiotech & Pharma (Biotechnology)Incorporated2021SEC CIK0001977037Offerings on file2
Source: SEC Form D structured data. Amounts are self-reported by the issuer on a notice filing — not audited, and cumulative across amendments. The website link is resolved automatically and may be wrong — tell us if it is. Full methodology →